v3.26.1
Legal proceedings and contingent liabilities - Legal proceedings (Details)
$ in Thousands
1 Months Ended
Jul. 31, 2026
patent
May 31, 2026
USD ($)
Feb. 28, 2026
patent
Jun. 30, 2025
USD ($)
Jul. 31, 2024
item
May 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Oct. 31, 2023
Apr. 30, 2022
USD ($)
Jun. 30, 2026
patent
Dec. 31, 2025
patent
Sep. 30, 2024
USD ($)
Jul. 31, 2020
USD ($)
Oct. 31, 2012
agreement
Forxiga patent proceedings, Australia                            
Disclosure of contingent liabilities [line items]                            
Number of patents claimed to be infringed | patent                     1      
Tagrisso Patent Proceedings, Russia | Russian Ministry of Health (MOH)                            
Disclosure of contingent liabilities [line items]                            
Number of appeals prior to dismissal | item         2                  
PARP Inhibitor Royalty Dispute                            
Disclosure of contingent liabilities [line items]                            
Number of royalty-bearing patent license agreements | agreement                           2
Forxiga patent proceedings, Europe | FRANCE                            
Disclosure of contingent liabilities [line items]                            
Number of patents being challenged | patent                   1        
Forxiga patent proceedings, Europe | PORTUGAL                            
Disclosure of contingent liabilities [line items]                            
Number of patents being challenged | patent                   1        
Forxiga patent proceedings, Europe | PORTUGAL | Trial for forxiga patent proceedings                            
Disclosure of contingent liabilities [line items]                            
Number of patent trials concluded | patent 1                          
Forxiga patent proceedings, Europe | POLAND                            
Disclosure of contingent liabilities [line items]                            
Number of patents invalidated | patent     1                      
Tagrisso US patent proceedings                            
Disclosure of contingent liabilities [line items]                            
Damages awarded, Value           $ 107,500                
Definiens commercial litigation                            
Disclosure of contingent liabilities [line items]                            
Damages awarded, Value             $ 46,000              
Amount of claim                         $ 140,000  
Syntimmune Milestone Litigation, US                            
Disclosure of contingent liabilities [line items]                            
Damages awarded, Value       $ 181,000                    
Damages received from counterparty   $ 11,100                        
Court decision on amount of milestone that had been reached                       $ 130,000    
University of Sheffield Contract Dispute, UK                            
Disclosure of contingent liabilities [line items]                            
Litigation settlement amount   $ 220,000                        
Enhertu patent proceedings                            
Disclosure of contingent liabilities [line items]                            
Damages awarded, Value                 $ 41,820          
Percentage of royalties on sales to pay to counterparty               8.00%            
Number of proceedings in which counterparty has disclaimed all patents | patent                     1